Amneal Pharmaceuticals (AMRX) Quick Ratio: History & Chart

Amneal Pharmaceuticals, Inc.(AMRX)

Drug Manufacturers - Specialty & Generic · Bridgewater, NJ

$20.40+0.04 (+0.22%)

Delayed quote: Oct 6, 2026, 2:45 PM EDT

About Amneal Pharmaceuticals, Inc.

Amneal Pharmaceuticals, Inc., operating alongside its various subsidiaries, is a diversified pharmaceutical company involved in the development, acquisition of licenses, manufacturing, marketing, and distribution of both generic and specialized medicinal products. These offerings span a multitude of delivery formats and target a wide range of therapeutic needs. Its operations are structured into three distinct divisions: Generics, Specialty, and AvKARE. The Generics division is responsible for creating, producing, and bringing to market a diverse portfolio of complex pharmaceutical formulations. This includes oral solid doses, injectable solutions, ophthalmic preparations, liquid medications, topical applications, softgels, inhalants, and transdermal patches, all catering to a broad spectrum of medical needs. Within the Specialty division, the company concentrates on the advancement, marketing, sales, and distribution of proprietary branded pharmaceuticals. Key therapeutic areas for this segment include neurological conditions, endocrine disorders, and parasitic ailments, among others. Notable offerings include Emverm, a chewable tablet prescribed for single or mixed parasitic infections such as pinworm and various hookworms; Rytary, designed for the management of Parkinson's disease; and Unithroid, used in treating hypothyroidism. The AvKARE segment primarily serves governmental entities, particularly the Department of Defense and the Department of Veterans Affairs, supplying them with pharmaceuticals, medical and surgical supplies, and related services. Additionally, this segment engages in the bulk distribution of bottled and unit-dose pharmaceuticals under its AvKARE and AvPAK brands, alongside medical and surgical items. It also manages the packaging and large-scale distribution of medications and nutritional supplements for its retail and institutional clientele. Products from Amneal reach consumers through a network comprising wholesale suppliers, third-party distributors, hospitals, large pharmacy chains, and independent drugstores. Its operational footprint extends across the United States, India, Ireland, and other international markets. Established in 2002, the company was initially incorporated as Atlas Holdings, Inc., before adopting the name Amneal Pharmaceuticals, Inc. in 2018. Its corporate headquarters are situated in Bridgewater, New Jersey.

Bridgewater, NJ

8,700 employees

www.amneal.com

Healthcare / Drug Manufacturers - Specialty & Generic

Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
CEO: Chirag K. Patel

View full financials

AMRX Quick Ratio (Acid-Test) Metrics

QUICK RATIO (ACID-TEST)

1.44

QUICK RATIO (ACID-TEST) AVG TTM

1.36

QUICK RATIO (ACID-TEST) AVG 3Y

1.10

QUICK RATIO (ACID-TEST) AVG 5Y

1.18

QUICK RATIO (ACID-TEST) AVG 10Y

1.33

QUICK RATIO (ACID-TEST) AVG 15Y

N/A

QUICK RATIO (ACID-TEST) AVG 20Y

N/A

CURRENT VS TTM AVG

+5.56%

CURRENT VS 3Y AVG

+30.12%

CURRENT VS 5Y AVG

+21.53%

CURRENT VS 10Y AVG

+8.42%

CURRENT VS 15Y AVG

N/A

CURRENT VS 20Y AVG

N/A

SECTOR MEDIAN · HEALTHCARE

3.35

median of 871 covered companies

CURRENT VS SECTOR MEDIAN

-57.11%

vs the sector median at left

NAME	MARKET CAP	QUICK RATIO (ACID-TEST)	TTM	3Y	5Y
Amneal Pharmaceuticals, Inc. (AMRX)	$6.51B	1.44	1.36	1.10	1.18
Hims & Hers Health, Inc. (HIMS)vs ›	$6.52B	0.87	1.56	2.48	3.39
Lantheus Holdings, Inc. (LNTH)vs ›	$6.51B	2.89	3.87	3.94	3.31
Immunovant, Inc. (IMVT)vs ›	$6.55B	7.27	10.13	10.82	12.77
Chemed Corporation (CHE)vs ›	$6.66B	0.89	1.19	1.21	1.11
Rhythm Pharmaceuticals, Inc. (RYTM)vs ›	$6.22B	3.20	3.62	5.38	6.45
Alkermes plc (ALKS)vs ›	$7.02B	1.85	2.92	2.56	2.40
Kodiak Sciences Inc. (KOD)vs ›	$5.96B	2.49	5.72	6.91	11.65
Ligand Pharmaceuticals Incorporated (LGND)vs ›	$5.95B	30.96	15.27	11.45	10.17
GRAIL Inc. (GRAL)vs ›	$5.93B	10.74	11.09	6.26	5.77

NAME

MARKET CAP

QUICK RATIO (ACID-TEST)

TTM

Amneal Pharmaceuticals, Inc. (AMRX)

$6.51B

1.44

1.36

1.10

1.18

Hims & Hers Health, Inc. (HIMS)vs ›

$6.52B

0.87

1.56

2.48

3.39

Lantheus Holdings, Inc. (LNTH)vs ›

$6.51B

2.89

3.87

3.94

3.31

Immunovant, Inc. (IMVT)vs ›

$6.55B

7.27

10.13

10.82

12.77

Chemed Corporation (CHE)vs ›

$6.66B

0.89

1.19

1.21

1.11

Rhythm Pharmaceuticals, Inc. (RYTM)vs ›

$6.22B

3.20

3.62

5.38

6.45

Alkermes plc (ALKS)vs ›

$7.02B

1.85

2.92

2.56

2.40

Kodiak Sciences Inc. (KOD)vs ›

$5.96B

2.49

5.72

6.91

11.65

Ligand Pharmaceuticals Incorporated (LGND)vs ›

$5.95B

30.96

15.27

11.45

10.17

GRAIL Inc. (GRAL)vs ›

$5.93B

10.74

11.09

6.26

5.77

Quick Ratio (Acid-Test) FAQ

What is the quick ratio (acid-test) for Amneal Pharmaceuticals, Inc. (AMRX)?

The quick ratio (acid-test) for AMRX stock is 1.44.

Is Amneal Pharmaceuticals, Inc.'s quick ratio (acid-test) high or low?

The quick ratio (acid-test) of 1.44 is 22% above its 5-year average of 1.18, near the high end of its 5-year range (0.82–1.59).

What is the TTM average quick ratio (acid-test) for Amneal Pharmaceuticals, Inc. (AMRX)?

The TTM average quick ratio (acid-test) for AMRX stock is 1.36.

What is the 3Y average quick ratio (acid-test) for Amneal Pharmaceuticals, Inc. (AMRX)?

The 3Y average quick ratio (acid-test) for AMRX stock is 1.10.

What is the 5Y average quick ratio (acid-test) for Amneal Pharmaceuticals, Inc. (AMRX)?

The 5Y average quick ratio (acid-test) for AMRX stock is 1.18.

What is the 10Y average quick ratio (acid-test) for Amneal Pharmaceuticals, Inc. (AMRX)?

The 10Y average quick ratio (acid-test) for AMRX stock is 1.33.

DATE	QUICK RATIO (ACID-TEST)
2026-06-30	1.44
2026-03-31	1.59
2025-12-31	1.48
2025-09-30	1.42
2025-06-30	0.88
2025-03-31	0.84
2024-12-31	0.86
2024-09-30	0.84
2024-06-30	0.82
2024-03-31	0.97
2023-12-31	0.94
2023-09-30	1.16
2023-06-30	1.12
2023-03-31	1.11
2022-12-31	1.17
2022-09-30	1.07
2022-06-30	1.03
2022-03-31	1.46
2021-12-31	1.52
2021-09-30	1.57
2021-06-30	1.55
2021-03-31	1.67
2020-12-31	1.57
2020-09-30	1.60
2020-06-30	1.58
2020-03-31	1.38
2019-12-31	1.51
2019-09-30	1.50
2019-06-30	1.41
2019-03-31	1.37
2018-12-31	1.50
2018-09-30	1.26
2018-06-30	1.25
2018-03-31	-0.89
2017-12-31	1.64
2017-09-30	1.60
2017-06-30	0.00
2017-03-31	0.00
2016-12-31	2.04

DATE

QUICK RATIO (ACID-TEST)

2026-06-30

1.44

2026-03-31

1.59

2025-12-31

1.48

2025-09-30

1.42

2025-06-30

0.88

2025-03-31

0.84

2024-12-31

0.86

2024-09-30

0.84

2024-06-30

0.82

2024-03-31

0.97

2023-12-31

0.94

2023-09-30

1.16

2023-06-30

1.12

2023-03-31

1.11

2022-12-31

1.17

2022-09-30

1.07

2022-06-30

1.03

2022-03-31

1.46

2021-12-31

1.52

2021-09-30

1.57

2021-06-30

1.55

2021-03-31

1.67

2020-12-31

1.57

2020-09-30

1.60

2020-06-30

1.58

2020-03-31

1.38

2019-12-31

1.51

2019-09-30

1.50

2019-06-30

1.41

2019-03-31

1.37

2018-12-31

1.50

2018-09-30

1.26

2018-06-30

1.25

2018-03-31

-0.89

2017-12-31

1.64

2017-09-30

1.60

2017-06-30

0.00

2017-03-31

0.00

2016-12-31

2.04

Quick Ratio (Acid-Test): 1.44

AMRX Quick Ratio

AMRX Average Quick Ratio (Acid-Test) Chart

AMRX Current vs Average Quick Ratio (Acid-Test) Chart

AMRX Quick Ratio (Acid-Test) Metrics

AMRX Competitors' Quick Ratio (Acid-Test)

Liquidity Comparison

Quick Ratio (Acid-Test) Formula & Definition

Quick Ratio (Acid-Test) FAQ

AMRX Quick Ratio (Acid-Test) History

Related Metrics